TLX 4.24% $19.19 telix pharmaceuticals limited

Forecasting Quarterly Sales Figures, page-60

  1. 1,691 Posts.
    lightbulb Created with Sketch. 721
    if

    Valuation. Newprice target of $10.35 per share equates to 20x FY23e revenue (WILSe:A$145M). Obvious caveats include major market approvals for ILLUCCIX which isthe sole current source of revenue in our model. Our unrisked PT stands at$14.00 per share. Pipeline assets (TLX250, TLX66, TLX101) account for 11% ofour risked SOTP valuation.


    back of envelope stuff

    22m for ten weeks then 26 m for twelve weeks or 104m per year
    big uplift from july 1 , say 25%

    makes annual circa $A145 pretty accurate
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
(20min delay)
Last
$19.19
Change
0.780(4.24%)
Mkt cap ! $6.421B
Open High Low Value Volume
$18.85 $19.19 $18.78 $22.02M 1.155M

Buyers (Bids)

No. Vol. Price($)
1 2216 $19.18
 

Sellers (Offers)

Price($) Vol. No.
$19.20 1000 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.